Fury, M. G., Baxi, S., Shen, R., Kelly, K. W., Lipson, B. L., Carlson, D., . . . Pfister, D. G. (2011). Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).

Fury, Matthew G., Shrujal Baxi, Ronglai Shen, Katherine W. Kelly, Brynna L. Lipson, Diane Carlson, Hilda Stambuk, Sofia Haque, and David G. Pfister. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.

Fury, Matthew G., et al. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.